Brinzolamide

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 466 publications

Abstract: Recognizing Early Signs of Primary Congenital Glaucoma in Infancy.

Abstract: Recognizing Early Signs of Primary Congenital Glaucoma in Infancy.

Journal: South Dakota medicine : the journal of the South Dakota State Medical Association

Published: July 29, 2026

Challenges and opportunities for developing selective carbonic anhydrase inhibitors and activators for vertebrate isoforms.

Challenges and opportunities for developing selective carbonic anhydrase inhibitors and activators for vertebrate isoforms.

Journal: The Enzymes

Published: July 22, 2026

Carbonic anhydrases I and II.

Carbonic anhydrases I and II.

Journal: The Enzymes

Published: July 22, 2026

Solid-state effects of Brinzolamide on sustained intravitreal release from hot-melt extruded PLGA implants.

Solid-state effects of Brinzolamide on sustained intravitreal release from hot-melt extruded PLGA implants.

Journal: International journal of pharmaceutics

Published: June 02, 2026

Dapagliflozin embedded polymeric nanomicelles for enhanced ocular drug delivery: A promising strategy for glaucoma therapy.

Dapagliflozin embedded polymeric nanomicelles for enhanced ocular drug delivery: A promising strategy for glaucoma therapy.

Journal: International journal of pharmaceutics

Published: April 27, 2026

Dapagliflozin embedded polymeric nanomicelles for enhanced ocular drug delivery: A promising strategy for glaucoma therapy.

Dapagliflozin embedded polymeric nanomicelles for enhanced ocular drug delivery: A promising strategy for glaucoma therapy.

Journal: International journal of pharmaceutics

Published: April 27, 2026

Corrigendum to "Brinzolamide encapsulated β-cyclodextrin-chondroitin sulfate nanocomplexes anchored chitosan/polycaprolactone nanofibers as an ocular insert for glaucoma treatment" [Mater. Today Bio 34 (2025) 102179].

Corrigendum to "Brinzolamide encapsulated β-cyclodextrin-chondroitin sulfate nanocomplexes anchored chitosan/polycaprolactone nanofibers as an ocular insert for glaucoma treatment" [Mater. Today Bio 34 (2025) 102179].

Journal: Materials today. Bio

Published: April 02, 2026

Alternate day vs daily topical brinzolamide for the treatment of cystic maculopathy in inherited rod cone retinal degenerations.

Alternate day vs daily topical brinzolamide for the treatment of cystic maculopathy in inherited rod cone retinal degenerations.

Journal: Ophthalmic genetics

Published: March 31, 2026

Intraocular pressure reduction attenuates form-deprivation myopia by modulating scleral extracellular matrix remodeling via the TGF-β1/Smad signaling pathway.

Intraocular pressure reduction attenuates form-deprivation myopia by modulating scleral extracellular matrix remodeling via the TGF-β1/Smad signaling pathway.

Journal: Experimental eye research

Published: March 18, 2026

Brinzolamide microsponge-loaded in situ gel for sustained ocular delivery: design, characterization and in vivo evaluation.

Brinzolamide microsponge-loaded in situ gel for sustained ocular delivery: design, characterization and in vivo evaluation.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: February 28, 2026

Severe metabolic acidosis with renal tubular acidosis features attributed to topical brinzolamide in a patient with stage 3 chronic kidney disease: a case report.

Severe metabolic acidosis with renal tubular acidosis features attributed to topical brinzolamide in a patient with stage 3 chronic kidney disease: a case report.

Journal: BMC nephrology

Published: February 17, 2026

Discovery of anti-glaucoma agents with dual hCA II inhibitory and nitric oxide-releasing activity and their neuroprotective effects.

Discovery of anti-glaucoma agents with dual hCA II inhibitory and nitric oxide-releasing activity and their neuroprotective effects.

Journal: European journal of medicinal chemistry

Published: February 13, 2026

Showing 1-12 of 466

Last Updated: 09/26/2026